Clinical Trials · NCT02354768

Evaluation of Lanreotide Efficacity in High Output Stoma: a Multicentric Randomized Study

TerminatedPhase 3Lanreotide (Prohibited)
Phase
Phase 3
Recruitment status
Terminated
Sponsor
University Hospital, Strasbourg, France
Enrollment
19
Start date
Oct 2015
Locations
6 sites, France
Primary endpoint
Number of ileostomy bags used per day
View Lanreotide compound reference